MA
RGEN icon

Montag & Associates’s Repligen RGEN Stock Holding History

Montag & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Sell
9
-1
-10% -$123 ﹤0.01% 916
2026
Q1 		$1.18K Hold
10
– – ﹤0.01% 888
2025
Q4 		$1.64K Sell
10
-1
-9% -$157 ﹤0.01% 883
2025
Q3 		$1.53K Sell
11
-1
-8% -$121 ﹤0.01% 955
2025
Q2 		$1.51K Hold
12
– – ﹤0.01% 880
2025
Q1 		$1.55K Buy
12
+1
+9% +$154 ﹤0.01% 915
2024
Q4 		$1.57K Buy
+11
New +$1.58K ﹤0.01% 910

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Montag & Associates's RGEN Position: Q2 2026 in Review

Montag & Associates reduced its Repligen (RGEN) stake by 10% in Q2 2026, selling an estimated $123 and leaving 9 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Montag & Associates first reported a position in RGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.64K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Montag & Associates held 9 shares of Repligen worth $1.17K as of Q2 2026.
  • Montag & Associates sold 1 Repligen share in Q2 2026, an estimated $123.
  • Repligen made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #916 holding.
  • Montag & Associates first reported a position in Repligen in Q4 2024 and has held it in 7 quarters since.
  • Montag & Associates's Repligen position peaked at $1.64K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.